Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elisé P. Wright"'
Autor:
Mahmoud A. S. Abdelhamid, Nicole M. Smith, Melanie C Grigg, Zoë A. E. Waller, Michelle O Ehiabor, Kelly L. Irving, Elisé P. Wright
Publikováno v:
Nucleic Acids Research
i-Motifs are widely used in nanotechnology, play a part in gene regulation and have been detected in human nuclei. As these structures are composed of cytosine, they are potential sites for epigenetic modification. In addition to 5-methyl- and 5-hydr
Publikováno v:
Biochemistry. 56(36)
Both 5-aza-2'-deoxycytidine (decitabine) and its primary breakdown product, 2'-deoxyriboguanylurea (GuaUre-dR), have been shown to act as mutagens and epimutagens that cause replication stress and alter both DNA methylation and gene expression patter
Publikováno v:
Nucleic Acids Research
i-Motifs are alternative DNA secondary structures formed in cytosine-rich sequences. Particular examples of these structures, traditionally assumed to be stable only at acidic pH, have been found to form under near-physiological conditions. To determ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16a2adbd79f0b8be79dada0caf1ad26c
https://ueaeprints.uea.ac.uk/id/eprint/62822/
https://ueaeprints.uea.ac.uk/id/eprint/62822/
Autor:
Zoë A. E. Waller, Henry A. Day, Klaus Pors, Leo J. E. Boswell, Ali Ibrahim, Clare E. M. Stevenson, Elisé P. Wright, Jeethendra Kumar, Camille Huguin
Publikováno v:
Scientific Reports
There are hundreds of ligands which can interact with G-quadruplex DNA, yet very few which target i-motif. To appreciate an understanding between the dynamics between these structures and how they can be affected by intervention with small molecule l
Publikováno v:
Chemical Communications (Cambridge, England)
i-Motif forming DNA sequences have previously been used for many different nanotechnological applications, but all have used changes in pH to fold the DNA. Here it is shown that Cu(ii) cations can be used to re-fold i-motifs into hairpin structures,
Autor:
Elise P. Wright, Matthew P. Padula, Vincent J. Higgins, Janice R. Aldrich-Wright, Jens R. Coorssen
Publikováno v:
Proteomes, Vol 2, Iss 4, Pp 501-526 (2014)
Many clinically available anticancer compounds are designed to target DNA. This commonality of action often yields overlapping cellular response mechanisms and can thus detract from drug efficacy. New compounds are required to overcome resistance mec
Externí odkaz:
https://doaj.org/article/b182f5a1d6ba4678b379498d1c20d156